Zacks: Brokerages Anticipate Stryker Co. (NYSE:SYK) Will Announce Earnings of $1.37 Per Share

Share on StockTwits

Analysts predict that Stryker Co. (NYSE:SYK) will report $1.37 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Ten analysts have made estimates for Stryker’s earnings, with estimates ranging from $1.08 to $1.50. Stryker posted earnings of $1.91 per share in the same quarter last year, which suggests a negative year-over-year growth rate of 28.3%. The business is scheduled to issue its next quarterly earnings results after the market closes on Thursday, October 29th.

According to Zacks, analysts expect that Stryker will report full year earnings of $6.29 per share for the current year, with EPS estimates ranging from $5.74 to $6.75. For the next financial year, analysts expect that the firm will post earnings of $8.84 per share, with EPS estimates ranging from $7.69 to $9.27. Zacks’ earnings per share calculations are an average based on a survey of research firms that follow Stryker.

Stryker (NYSE:SYK) last announced its earnings results on Thursday, July 30th. The medical technology company reported $0.64 earnings per share for the quarter, topping analysts’ consensus estimates of $0.62 by $0.02. Stryker had a net margin of 11.38% and a return on equity of 20.53%. The business had revenue of $2.76 billion during the quarter, compared to the consensus estimate of $2.63 billion.

A number of research firms have commented on SYK. Citigroup raised their price target on shares of Stryker from $227.00 to $232.00 and gave the stock a “buy” rating in a report on Friday, July 31st. Morgan Stanley raised their price target on shares of Stryker from $215.00 to $225.00 and gave the stock an “overweight” rating in a report on Friday, July 31st. Credit Suisse Group raised their price target on shares of Stryker from $237.00 to $243.00 and gave the stock an “outperform” rating in a report on Friday, July 31st. Oppenheimer restated a “hold” rating and issued a $215.00 price target on shares of Stryker in a report on Friday, July 31st. Finally, Needham & Company LLC restated a “hold” rating on shares of Stryker in a report on Friday, July 31st. Three analysts have rated the stock with a sell rating, eight have issued a hold rating, sixteen have given a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $217.88.

In other Stryker news, CEO Kevin Lobo sold 25,855 shares of Stryker stock in a transaction dated Friday, July 31st. The shares were sold at an average price of $190.80, for a total value of $4,933,134.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 6.80% of the company’s stock.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Evolution Wealth Advisors LLC raised its position in shares of Stryker by 64.4% in the second quarter. Evolution Wealth Advisors LLC now owns 143 shares of the medical technology company’s stock valued at $26,000 after purchasing an additional 56 shares during the period. Demars Financial Group LLC bought a new stake in shares of Stryker in the second quarter valued at approximately $32,000. Balentine LLC bought a new stake in shares of Stryker in the first quarter valued at approximately $31,000. NuWave Investment Management LLC bought a new stake in shares of Stryker in the second quarter valued at approximately $35,000. Finally, Campbell Wealth Management bought a new stake in shares of Stryker in the second quarter valued at approximately $45,000. 71.02% of the stock is currently owned by institutional investors.

NYSE:SYK traded down $0.37 during trading hours on Monday, reaching $208.30. The company had a trading volume of 966,300 shares, compared to its average volume of 1,787,215. The company has a quick ratio of 2.12, a current ratio of 2.91 and a debt-to-equity ratio of 0.93. The firm has a market cap of $78.08 billion, a price-to-earnings ratio of 49.48, a P/E/G ratio of 3.47 and a beta of 0.83. The business’s 50-day simple moving average is $198.99 and its two-hundred day simple moving average is $186.17. Stryker has a twelve month low of $124.54 and a twelve month high of $226.30.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a $0.575 dividend. This represents a $2.30 annualized dividend and a yield of 1.10%. The ex-dividend date is Tuesday, September 29th. Stryker’s dividend payout ratio is 27.85%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Further Reading: Yield Curve

Get a free copy of the Zacks research report on Stryker (SYK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply